| 1 |
73 |
A |
G |
. |
0.998 |
. |
. |
PASS |
No References
|
Variant Details |
| 2 |
259 |
A |
G |
. |
0.997 |
. |
. |
PASS |
No References
|
Variant Details |
| 3 |
263 |
A |
G |
. |
0.997 |
. |
. |
PASS |
No References
|
Variant Details |
| 4 |
302 |
A |
G |
. |
0.014 |
. |
. |
base_qual;blacklisted_site;strand_bias;weak_evidence |
No References
|
Variant Details |
| 5 |
310 |
- |
C |
. |
0.995 |
. |
. |
blacklisted_site |
No References
|
Variant Details |
| 6 |
489 |
T |
C |
. |
0.997 |
. |
. |
PASS |
No References
|
Variant Details |
| 7 |
514 |
CA |
- |
. |
0.996 |
. |
. |
PASS |
No References
|
Variant Details |
| 8 |
715 |
G |
A |
. |
0.011 |
. |
. |
PASS |
No References
|
Variant Details |
| 9 |
750 |
A |
G |
. |
0.999 |
. |
. |
PASS |
No References
|
Variant Details |
| 10 |
930 |
G |
C |
. |
0.998 |
. |
. |
PASS |
No References
|
Variant Details |
| 11 |
1438 |
A |
G |
. |
0.998 |
. |
. |
PASS |
No References
|
Variant Details |
| 12 |
1598 |
G |
A |
. |
0.998 |
. |
. |
PASS |
No References
|
Variant Details |
| 13 |
2457 |
A |
- |
. |
0.006 |
. |
. |
weak_evidence |
No References
|
Variant Details |
| 14 |
2706 |
A |
G |
. |
0.992 |
. |
. |
PASS |
No References
|
Variant Details |
| 15 |
3074 |
A |
T |
. |
0.006 |
. |
. |
weak_evidence |
No References
|
Variant Details |
| 16 |
3101 |
A |
T |
. |
0.006 |
. |
. |
weak_evidence |
No References
|
Variant Details |
| 17 |
3583 |
A |
C |
MT-ND1 |
0.008 |
. |
. |
base_qual;strand_bias;weak_evidence |
References (1)
|
Variant Details |
| 18 |
3806 |
C |
T |
MT-ND1 |
0.005 |
. |
. |
weak_evidence |
No References
|
Variant Details |
| 19 |
4769 |
A |
G |
. |
0.995 |
. |
. |
PASS |
No References
|
Variant Details |
| 20 |
7028 |
C |
T |
. |
0.998 |
. |
. |
PASS |
No References
|
Variant Details |
| 21 |
7107 |
G |
T |
MT-CO1 |
0.007 |
. |
. |
weak_evidence |
No References
|
Variant Details |
| 22 |
7121 |
C |
G |
MT-CO1 |
0.007 |
. |
. |
weak_evidence |
No References
|
Variant Details |
| 23 |
7124 |
A |
T |
MT-CO1 |
0.007 |
. |
. |
weak_evidence |
No References
|
Variant Details |
| 24 |
7706 |
G |
A |
MT-CO2 |
0.014 |
Alpers-Huttenlocher-like |
Reported |
PASS |
References (5)
|
Variant Details |
| 25 |
7714 |
C |
A |
MT-CO2 |
0.006 |
. |
. |
weak_evidence |
No References
|
Variant Details |
| 26 |
7778 |
T |
C |
MT-CO2 |
0.027 |
. |
. |
PASS |
No References
|
Variant Details |
| 27 |
7793 |
G |
A |
MT-CO2 |
0.005 |
. |
. |
weak_evidence |
No References
|
Variant Details |
| 28 |
8666 |
A |
C |
MT-ATP6 |
0.008 |
. |
. |
base_qual;weak_evidence |
No References
|
Variant Details |
| 29 |
8683 |
A |
C |
MT-ATP6 |
0.009 |
. |
. |
base_qual;weak_evidence |
No References
|
Variant Details |
| 30 |
8701 |
A |
G |
MT-ATP6 |
0.997 |
. |
. |
PASS |
References (102)
|
Variant Details |
| 31 |
8860 |
A |
G |
MT-ATP6 |
0.979 |
. |
. |
PASS |
References (124)
|
Variant Details |
| 32 |
9377 |
A |
G |
. |
0.998 |
. |
. |
PASS |
No References
|
Variant Details |
| 33 |
9512 |
C |
A |
. |
0.006 |
. |
. |
base_qual;weak_evidence |
No References
|
Variant Details |
| 34 |
9540 |
T |
C |
. |
0.996 |
. |
. |
PASS |
No References
|
Variant Details |
| 35 |
9552 |
T |
C |
MT-CO3 |
0.004 |
. |
. |
weak_evidence |
No References
|
Variant Details |
| 36 |
10162 |
C |
A |
MT-ND3 |
0.013 |
. |
. |
weak_evidence |
No References
|
Variant Details |
| 37 |
10165 |
C |
A |
MT-ND3 |
0.009 |
. |
. |
weak_evidence |
No References
|
Variant Details |
| 38 |
10359 |
A |
G |
MT-ND3 |
0.009 |
. |
. |
weak_evidence |
No References
|
Variant Details |
| 39 |
10398 |
A |
G |
MT-ND3 |
0.995 |
PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy |
Reported; lineage L & M marker, also hg IJK |
PASS |
References (221)
|
Variant Details |
| 40 |
10400 |
C |
T |
. |
0.995 |
. |
. |
PASS |
No References
|
Variant Details |
| 41 |
10797 |
C |
A |
MT-ND4 |
0.010 |
. |
. |
weak_evidence |
No References
|
Variant Details |
| 42 |
10873 |
T |
C |
. |
0.997 |
. |
. |
PASS |
No References
|
Variant Details |
| 43 |
11004 |
G |
A |
MT-ND4 |
0.007 |
. |
. |
weak_evidence |
No References
|
Variant Details |
| 44 |
11076 |
T |
C |
MT-ND4 |
0.005 |
. |
. |
weak_evidence |
No References
|
Variant Details |
| 45 |
11150 |
G |
A |
MT-ND4 |
0.998 |
Found in a Multiple Sclerosis patient |
Reported |
PASS |
References (4)
|
Variant Details |
| 46 |
11719 |
G |
A |
. |
0.998 |
. |
. |
PASS |
No References
|
Variant Details |
| 47 |
12705 |
C |
T |
. |
0.998 |
. |
. |
PASS |
No References
|
Variant Details |
| 48 |
12973 |
C |
T |
. |
0.998 |
. |
. |
PASS |
No References
|
Variant Details |
| 49 |
13761 |
A |
C |
. |
0.008 |
. |
. |
base_qual;strand_bias;weak_evidence |
No References
|
Variant Details |
| 50 |
13773 |
A |
C |
MT-ND5 |
0.007 |
. |
. |
base_qual;strand_bias;weak_evidence |
No References
|
Variant Details |
| 51 |
14528 |
C |
T |
MT-ND6 |
0.035 |
. |
. |
PASS |
No References
|
Variant Details |
| 52 |
14766 |
C |
T |
MT-CYB |
0.998 |
. |
. |
PASS |
References (113)
|
Variant Details |
| 53 |
14783 |
T |
C |
. |
0.998 |
. |
. |
PASS |
No References
|
Variant Details |
| 54 |
14845 |
C |
T |
. |
0.998 |
. |
. |
PASS |
No References
|
Variant Details |
| 55 |
15043 |
G |
A |
. |
0.998 |
. |
. |
PASS |
No References
|
Variant Details |
| 56 |
15301 |
G |
A |
. |
0.998 |
. |
. |
PASS |
No References
|
Variant Details |
| 57 |
15326 |
A |
G |
MT-CYB |
0.998 |
. |
. |
PASS |
References (116)
|
Variant Details |
| 58 |
16111 |
C |
A |
. |
0.998 |
. |
. |
PASS |
No References
|
Variant Details |
| 59 |
16115 |
C |
A |
. |
0.006 |
. |
. |
PASS |
No References
|
Variant Details |
| 60 |
16129 |
- |
AA |
. |
0.003 |
. |
. |
weak_evidence |
No References
|
Variant Details |
| 61 |
16130 |
G |
A |
. |
0.003 |
. |
. |
weak_evidence |
No References
|
Variant Details |
| 62 |
16133 |
C |
- |
. |
0.003 |
. |
. |
weak_evidence |
No References
|
Variant Details |
| 63 |
16137 |
- |
GCGGTTGTTGATGGGTGAGTC |
. |
0.003 |
. |
. |
weak_evidence |
No References
|
Variant Details |
| 64 |
16140 |
T |
C |
. |
0.999 |
. |
. |
PASS |
No References
|
Variant Details |
| 65 |
16209 |
T |
C |
. |
0.999 |
. |
. |
PASS |
No References
|
Variant Details |
| 66 |
16222 |
C |
T |
. |
0.003 |
. |
. |
weak_evidence |
No References
|
Variant Details |
| 67 |
16223 |
C |
T |
. |
0.999 |
. |
. |
PASS |
No References
|
Variant Details |
| 68 |
16274 |
G |
A |
. |
0.002 |
. |
. |
weak_evidence |
No References
|
Variant Details |
| 69 |
16278 |
C |
T |
. |
0.002 |
. |
. |
weak_evidence |
No References
|
Variant Details |
| 70 |
16284 |
A |
G |
. |
0.002 |
. |
. |
weak_evidence |
No References
|
Variant Details |
| 71 |
16288 |
T |
C |
. |
0.002 |
. |
. |
weak_evidence |
No References
|
Variant Details |
| 72 |
16304 |
T |
C |
. |
0.998 |
. |
. |
PASS |
No References
|
Variant Details |
| 73 |
16311 |
T |
C |
. |
0.999 |
. |
. |
PASS |
No References
|
Variant Details |
| 74 |
16352 |
T |
C |
. |
0.999 |
. |
. |
PASS |
No References
|
Variant Details |
| 75 |
16353 |
C |
T |
. |
0.999 |
. |
. |
PASS |
No References
|
Variant Details |